VVN461 ophthalmic solution
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for VVN461 ophthalmic solution, covering 2025-01-27 to 2025-06-10. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery [Phase 2]